S. E. Salmon

5.3k citations
78 papers · 3.9k · 1 hit paper · h-index 33

Impact in

  • Hematology top 1%
    • Multiple Myeloma Research and Treatments
  • Oncology top 1%
    • Drug Transport and Resistance Mechanisms
    • Cancer Treatment and Pharmacology

Papers in

    • Cancer therapeutics and mechanisms 11
    • Protein Degradation and Inhibitors 7
    • Chemical Synthesis and Analysis 5
    • Cancer Treatment and Pharmacology 19
    • Drug Transport and Resistance Mechanisms 5
    • Cancer Cells and Metastasis 4

S. E. Salmon

76 papers receiving 3.5k citations

S. E. Salmon's Hit Papers

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. 1989 · 478 citations
4780+12+24Years since publication100200300400

Peers

S. E. Salmon
Comparison fields: 5 of 121
  • Hematology 833
  • Oncology 1.9k
  • Genetics 297
  • Cancer Research 365
  • Molecular Biology 1.7k
Replace Raymond Taetle with:
Raymond Taetle United States
E.H. Cooper United Kingdom
Anne W. Hamburger United States
George Morstyn Australia
Benjamin Drewinko United States
Fabien Calvo France
Albert Deisseroth United States
A. B. Deisseroth United States
F Zintl Germany
Bayard Clarkson United States
S. E. Salmon relative to Raymond Taetle United States Raymond Taetle's profile →
Citations per field
00.5×1.5×
Raymond Taetle · 1×
Citations per year

Countries citing papers authored by S. E. Salmon

Since Specialization
Citations

This map shows the geographic impact of S. E. Salmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. E. Salmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. E. Salmon more than expected).

Fields of papers citing papers by S. E. Salmon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. E. Salmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. E. Salmon. The network helps show where S. E. Salmon may publish in the future.

Co-authors

The 25 scholars most cited alongside S. E. Salmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. E. Salmon Line = papers co-authored together S. E. Salmon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.
Hit paper breakdown →
1989478
2 1977300
3 1993239
4 1974215
5
Application of a human tumor colony-forming assay to new drug screening.
1985179
6 1991153
7 1967125
8 1983119
9 1983113
10 1994102
11 198394
12
Development of an agar-methyl cellulose clonogenic assay for cells in transitional cell carcinoma of the human bladder.
197980
13
Cloning of human tumor stem cells
198078
14
Human tumor colony assay and chemosensitivity testing.
198476
15 199376
16 198169
17 198165
18
Peptide-encoding for structure determination of nonsequenceable polymers within libraries synthesized and tested on solid-phase supports.
199363
19 197362
20 198361

About S. E. Salmon

S. E. Salmon is a scholar working on Molecular Biology, Oncology, Hematology, Immunology and Cancer Research, having authored 78 papers that have together received 3.9k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (19 papers), Multiple Myeloma Research and Treatments (19 papers), Cancer therapeutics and mechanisms (11 papers), Pharmacogenetics and Drug Metabolism (8 papers), Protein Degradation and Inhibitors (7 papers), Chemical Synthesis and Analysis (5 papers), Drug Transport and Resistance Mechanisms (5 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Hematology (833 citations), Oncology (1.9k citations), Genetics (297 citations), Cancer Research (365 citations) and Molecular Biology (1.7k citations). S. E. Salmon has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include William S. Dalton, Thomas M. Grogan, Charles W. Taylor, DavidS. Alberts, Paul S. Meltzer, Rik J. Scheper, TP Miller, B G M Durie, Thomas E. Moon and H. Benfer Kaltreider. Their work appears in journals such as Journal of Clinical Oncology, Recent results in cancer research, Cancer Chemotherapy and Pharmacology, British Journal of Cancer and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact